CHAPTER I GENERAL PROVISIONS
Article 1(Purpose) #
The purpose of this Act is to prescribe matters necessary for hospice and palliative care and life-sustaining treatment for patients at the end of life, determination to terminate, etc., such life-sustaining treatment, and the implementation thereof, and thereby to protect the dignity and value of human beings by assuring the best interests of the patients and by respecting their self-determination.
Article 2(Definitions) #
The definitions of terms used in this Act are as follows: <Amended on Mar. 27, 2018>
1. The term "end-of-life process" means a state of imminent death, in which there is no possibility of revitalization or recovery despite treatment, and symptoms worsen rapidly;
2. The term "patient at the end of life" means a person who has received a medical prognosis under Article 16, from the doctor in charge and one medical specialist in the relevant field that he or she is at the end-of-life stage;
3. The term "terminal patient" means a patient who has been diagnosed as expected to die within a few months from the doctor in charge and one medical specialist in the relevant field in accordance with the procedures and guidelines prescribed by Ordinance of the Ministry of Health and Welfare, because there is no possibility of a fundamental recovery, and the symptoms gradually worsen despite proactive treatment:
(a) Deleted; <Mar. 27, 2018>
(b) Deleted; <Mar. 27, 2018>
(c) Deleted; <Mar. 27, 2018>
(d) Deleted. <Mar. 27, 2018>
(e) Deleted; <Mar. 27, 2018>
4. The term "life-sustaining treatment" means medical treatment by cardiopulmonary resuscitation, hemodialysis, administering anticancer drugs, mechanical ventilation, etc. to a patient at the end of life, as prescribed by Presidential Decree, which only prolong the process of dying without curative effect;
5. The term "determination to terminate, etc. life-sustaining treatment" means a decision made to decline or discontinue life-sustaining treatments for a patient at the end of life;